Pancreatic Cancer Research

ResearcherServicio Gallego de SaludActive in the last 2 years

África González‐Fernández

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9226-4825; OpenAlex author ID A5001520255. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 6

  1. CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer. Co-author DOI 10.1016/j.tranon.2026.102993↗
  2. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. First author DOI 10.1016/j.addr.2025.115638↗
  3. Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. Co-author DOI 10.1016/j.ijpharm.2025.126155↗
  4. Translational studies on pancreatic cancer and gastric cancer: a methodology in PhD thesis. Co-author DOI 10.3389/fphar.2025.1604017↗
  5. Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice. Last author DOI 10.3389/fimmu.2023.1153724↗
  6. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. Co-author DOI 10.3390/ph15070824↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Immacolata Maietta · 4 shared papers, 2022–2026 · strength 1.15
  2. Rosana Simón‐Vázquez · 4 shared papers, 2022–2025 · strength 1.10
  3. Amparo Martínez-Pérez · 2 shared papers, 2022–2023 · strength 0.40
  4. Jessie Santoro · 1 shared paper, 2026 · strength 0.27
  5. Mathilde Resell · 1 shared paper, 2025 · strength 0.27
  6. Chun‐Mei Zhao · 1 shared paper, 2025 · strength 0.27
  7. Timothy Cragin Wang · 1 shared paper, 2025 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.